Flumedroxone
 | |
 | |
| Clinical data | |
|---|---|
| Other names | 17α-Hydroxy-6α-(trifluoromethyl)pregn-4-ene-3,20-dione; 6α-Trifluoromethyl-17α-hydroxyprogesterone |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID |
|
| ChemSpider |
|
| UNII |
|
| ChEMBL |
|
| CompTox Dashboard (EPA) |
|
| Chemical and physical data | |
| Formula | C22H29F3O3 |
| Molar mass | 398.466 g·mol−1 |
| 3D model (JSmol) |
|
| |
| |
| (verify) | |
Flumedroxone is a steroidal progestogen of the 17α-hydroxyprogesterone group that was never marketed.[1] The C17α acetate ester of flumedroxone, flumedroxone acetate, has been marketed as an antimigraine drug.[1]
References
- ^ a b J Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 560–. ISBN 978-1-4757-2085-3.
